Timedora
Free Online Flashcard Deck

2 Heparin and Low-Molecular-Weight Heparins Free Online FlashCards

Study 2 Heparin and Low-Molecular-Weight Heparins with 12 free online flashcards. Review key terms, definitions, and concepts with this interactive flashcard deck.

12 cards
01
Front

What are two common clinical purposes of heparin or LMWH?

Back

They are used to prevent venous thromboembolism in at-risk patients and to treat conditions such as deep-vein thrombosis or pulmonary embolism.

02
Front

How do common administration routes differ for UFH and LMWH?

Back

UFH is commonly given intravenously or subcutaneously; LMWHs such as enoxaparin are usually given subcutaneously.

03
Front

Which tests commonly guide adjustment of a UFH infusion?

Back

A continuous UFH infusion is commonly adjusted using aPTT or an anti-factor Xa assay calibrated for UFH, according to the local protocol.

04
Front

Are PT/INR or aPTT routinely used to adjust enoxaparin?

Back

Routine coagulation-test adjustment is generally unnecessary for enoxaparin; PT/INR and aPTT do not adequately measure its anticoagulant effect.

05
Front

What baseline checks are important before heparin therapy?

Back

Check baseline blood counts, including platelets, and relevant coagulation tests; assess kidney function where relevant, particularly with LMWH.

06
Front

What should be suspected if a patient on heparin develops black stools and dizziness?

Back

Suspect clinically important bleeding, potentially gastrointestinal hemorrhage. Promptly notify the treating clinician and assess the patient.

07
Front

What serious reaction is suggested by a platelet fall with new thrombosis on heparin?

Back

HIT with thrombosis is concerning when a substantial platelet fall occurs alongside a new thrombosis during heparin treatment.

08
Front

How does protamine reverse UFH compared with enoxaparin?

Back

Protamine reverses UFH; its reversal of enoxaparin is incomplete.

09
Front

When might anti-factor Xa testing be considered for enoxaparin?

Back

Anti-factor Xa measurement may be considered in selected situations, such as renal impairment or when abnormal coagulation results or bleeding raise concern.

10
Front

What should be monitored during heparin treatment?

Back

Monitor for bleeding and follow platelet counts and other tests as appropriate for the drug, dose, patient, and local protocol.

11
Front

What is a key administration precaution for heparin products?

Back

Use the prescribed route and dose, and follow product-specific injection instructions. Heparin and LMWH are not given orally.

12
Front

What are key next steps when HIT is moderately or highly suspected?

Back

With intermediate or high suspicion, stop all heparin exposure, including flushes, urgently evaluate for HIT, and generally use a non-heparin anticoagulant while testing proceeds.